CAM
CLB icon

Congress Asset Management’s Core Laboratories CLB Stock Holding History

Congress Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,687,703
Closed -$34.2M – 359
2024
Q2 		$34.2M Buy
1,687,703
+80,958
+5% +$1.43M 0.25% 113
2024
Q1 		$27.4M Buy
1,606,745
+240,989
+18% +$3.79M 0.2% 119
2023
Q4 		$24.1M Buy
1,365,756
+240,893
+21% +$4.85M 0.19% 119
2023
Q3 		$27M Buy
1,124,863
+154,608
+16% +$3.79M 0.24% 112
2023
Q2 		$22.6M Buy
970,255
+191,238
+25% +$4.32M 0.2% 118
2023
Q1 		$17.2M Buy
779,017
+67,196
+9% +$1.57M 0.16% 125
2022
Q4 		$14.4M Buy
711,821
+11,113
+2% +$215K 0.14% 132
2022
Q3 		$9.45M Buy
700,708
+192,579
+38% +$3.25M 0.1% 159
2022
Q2 		$10.1M Buy
508,129
+81,359
+19% +$2.16M 0.1% 159
2022
Q1 		$13.5M Buy
+426,770
New +$12M 0.11% 136
2020
Q1 		– Sell
-59,846
Closed -$2.25M – 334
2019
Q4 		$2.25M Sell
59,846
-760
-1% -$34.1K 0.03% 241
2019
Q3 		$2.83M Buy
60,606
+6,478
+12% +$301K 0.04% 235
2019
Q2 		$2.83M Buy
54,128
+45,857
+554% +$2.69M 0.04% 249
2019
Q1 		$570K Buy
8,271
+1,449
+21% +$97.1K 0.01% 314
2018
Q4 		$407K Buy
6,822
+462
+7% +$39.9K 0.01% 334
2018
Q3 		$737K Buy
6,360
+22
+0.3% +$2.48K 0.01% 323
2018
Q2 		$800K Buy
6,338
+70
+1% +$8.52K 0.01% 312
2018
Q1 		$678K Sell
6,268
-861
-12% -$95.3K 0.01% 330
2017
Q4 		$781K Sell
7,129
-96
-1% -$9.58K 0.01% 324
2017
Q3 		$713K Sell
7,225
-551,537
-99% -$53.5M 0.01% 343
2017
Q2 		$56.6M Buy
558,762
+45,258
+9% +$4.88M 1.01% 50
2017
Q1 		$59.3M Buy
513,504
+87,896
+21% +$10.2M 1.13% 39
2016
Q4 		$51.1M Buy
425,608
+56,100
+15% +$6.21M 1.07% 43
2016
Q3 		$41.5M Buy
369,508
+56,618
+18% +$6.52M 0.92% 63
2016
Q2 		$38.8M Buy
312,890
+30,040
+11% +$3.63M 0.9% 64
2016
Q1 		$31.8M Buy
282,850
+35,025
+14% +$3.64M 0.77% 71
2015
Q4 		$26.9M Buy
247,825
+3,079
+1% +$352K 0.67% 71
2015
Q3 		$24.4M Buy
244,746
+37,753
+18% +$4.11M 0.63% 76
2015
Q2 		$23.6M Sell
206,993
-37,661
-15% -$4.57M 0.68% 60
2015
Q1 		$25.6M Buy
244,654
+86,208
+54% +$9.18M 0.61% 71
2014
Q4 		$19.1M Sell
158,446
-16,814
-10% -$2.21M 0.49% 74
2014
Q3 		$25.6M Buy
175,260
+17,869
+11% +$2.76M 0.66% 49
2014
Q2 		$26.3M Buy
157,391
+15,332
+11% +$2.73M 0.67% 45
2014
Q1 		$28.2M Buy
142,059
+53,205
+60% +$10M 0.71% 41
2013
Q4 		$17M Sell
88,854
-21,743
-20% -$4.05M 0.44% 46
2013
Q3 		$18.7M Buy
110,597
+2,096
+2% +$325K 0.52% 44
2013
Q2 		$16.5M Buy
+108,501
New +$15.4M 0.49% 45

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Congress Asset Management's CLB Position: Q3 2024 in Review

Congress Asset Management sold out of Core Laboratories (CLB) in Q3 2024, closing a stake of 1,687,703 shares — an estimated $34.2M sold.

Congress Asset Management first reported a position in CLB in Q2 2013 and held it in 37 quarters. The position peaked at $59.3M in Q1 2017. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

  • Congress Asset Management reported no remaining Core Laboratories position as of Q3 2024 after selling out during the quarter.
  • Congress Asset Management sold 1,687,703 Core Laboratories shares in Q3 2024, an estimated $34.2M.
  • Congress Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 37 quarters.
  • Congress Asset Management's Core Laboratories position peaked at $59.3M in Q1 2017.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on Congress Asset Management's 13F filing for Q3 2024, filed 28 Oct 2024.